Clinical Trials

20 enrolled

Leukemia, Lymphoma, Non-Hodgkin, Motor Activity, Neoplasms

NCT04856215 2023-10-03

RITII

25 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia

NCT04504526 2023-09-15

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

50 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

NCT01004640 2023-09-14

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

MyeloidOther hematologic neoplasm

60 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00900224 2023-08-31

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

529 enrolled

Congenital Abnormalities, Leukemia

NCT04965649 2023-08-30

TIPHI

Leukemia, Leukemia, Myeloid

NCT05932173 2023-07-11

A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies

60 enrolled

Leukemia, Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT05576532 2023-06-28

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04265963 2023-04-18

CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia

45 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04271410 2023-04-18

CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma

80 enrolled

Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04271800 2023-04-18

Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma

40 enrolled

Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04272125 2023-04-18

Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia

40 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT02931942 2023-03-16

Changing Over Time of Ascorbic Acid After Chemotherapy

Other hematologic neoplasmPlasma cellThoracic

150 enrolled

Leukemia, Lung Neoplasms, Leukemia, Myeloid, Acute, Neoplasms, Plasma Cell

NCT03846362 2023-03-16

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

Phase 3 Unknown

500 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT05495035 2023-03-02

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

22 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04688021 2023-02-21

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

46 enrolled

Graft vs Host Disease, Leukemia

NCT05672420 2023-01-05

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

181 enrolled

Anemia, Hemorrhage, Infections, Leukemia, Lymphoma, Multiple Myeloma, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT05649371 2022-12-14

Multiphasic Prehab Allo-HSCT

Phase NA Unknown

60 enrolled

Leukemia, Motor Activity

NCT04100187 2022-12-01

Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia

100 enrolled

Leukemia

NCT05291390 2022-11-29

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

200 enrolled

Phase EARLY_PHASE1 Unknown

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05519384 2022-11-28

Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia

12 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT02643888 2022-10-31

Pre-existing Kinase Domain Mutations in Ph-positive Leukemias

BreastGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmThoracic

Leukemia

NCT05227898 2022-10-25

RESTORE

Phase NA Unknown

352 enrolled

Breast Neoplasms, Colonic Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT03825367 2022-10-12

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

13 enrolled

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT04033627 2022-09-29

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

Phase NA Unknown

Disease, Graft vs Host Disease, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04684472 2022-09-26

Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies

18 enrolled

Leukemia, Lymphoma, B-Cell

NCT04352556 2022-09-23

COVID19-hematological Malignancies: the Italian Hematology Alliance

LymphoidOther hematologic neoplasmPlasma cell

250 enrolled

COVID-19, Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT05473325 2022-08-15

BRANCH-P

OtherOther hematologic neoplasm

2,000 enrolled

Acquired Immunodeficiency Syndrome, Alzheimer Disease, Appendicitis, Arthritis, Bronchitis, Bulimia, Cardiovascular Diseases, Cellulitis, Depression, Diabetes Mellitus, Dyspepsia, Eczema, Fibrosis, Gout, Heart Diseases, Hypercholesterolemia, Hypersensitivity, Infections, Infectious Mononucleosis, Influenza, Human, Intestinal Diseases, Leukemia, Liver Diseases, Alcoholic, Neoplasms, Obesity, Osteoporosis, HIV Infections, Renal Insufficiency, Chronic

NCT05480501 2022-07-29

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

Phase EARLY_PHASE1 Unknown

9 enrolled

Burkitt Lymphoma, Leukemia

NCT05212584 2022-07-06

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

24 enrolled

Leukemia, Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05445765 2022-07-06

Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia

10 enrolled

Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03564470 2022-07-01

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Phase 2/3 Unknown

120 enrolled

Leukemia, Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04632316 2022-06-21

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

33 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04709458 2022-05-03

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

MyeloidOther hematologic neoplasm

10 enrolled

Leukemia, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT05309213 2022-04-04

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

58 enrolled

Burkitt Lymphoma, Leukemia

NCT05203809 2022-01-24

THERMAL

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

20 enrolled

Body Temperature Changes, Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell, Febrile Neutropenia

NCT05164042 2021-12-20

CAR-T

20 enrolled

Leukemia

NCT04722952 2021-12-03

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

Phase 3 Unknown

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT04014894 2021-11-12

ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma

9 enrolled

Leukemia, Lymphoma

NCT04037189 2021-10-01

Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia

250 enrolled

Ataxia Telangiectasia, Leukemia, Lymphoma

NCT05061147 2021-10-01

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

MyeloidOther hematologic neoplasm

100 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03798509 2021-08-31

Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive Leukemia

18 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00558519 2021-08-18

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

318 enrolled 9 charts